Login to Your Account



Pharma: Clinic Roundup


Wednesday, March 6, 2013
• UCB SA, of Brussels, Belgium, reported results from a Phase III study showing that lacosamide monotherapy met the primary endpoint, with a significantly lower exit rate in adults with partial-onset seizures with or without secondary generalization compared with historical controls.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription